Key Events This Week
2 Mar: Stock hits 52-week low of Rs.11.69 and lower circuit at Rs.11.59
4 Mar: New 52-week low recorded at Rs.11.21 amid continued downtrend
6 Mar: Week closes at Rs.11.80, down 3.20% for the week
Mar 20
BSE+NSE Vol: 3.46 lacs

Nectar Lifescience Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.10.85 today, marking a significant decline in its stock price amid ongoing financial and market pressures. This fresh low comes after a sustained period of underperformance relative to broader market indices and sector peers.
Read full news article
2 Mar: Stock hits 52-week low of Rs.11.69 and lower circuit at Rs.11.59
4 Mar: New 52-week low recorded at Rs.11.21 amid continued downtrend
6 Mar: Week closes at Rs.11.80, down 3.20% for the week
Mar 9: Lower circuit hit amid intense selling pressure
Mar 10: Stock falls to fresh 52-week low of Rs.11.21
Mar 13: New 52-week low of Rs.10.89 recorded
Mar 13: Week closes at Rs.11.13 (-5.68%)

Nectar Lifescience Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.10.89 today, marking a significant decline amid a broader market downturn and persistent company-specific headwinds.
Read full news article
Nectar Lifescience Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Nectar Lifescience Ltd has declined to a fresh 52-week low, closing near Rs 11.21, marking a significant downturn in its stock performance amid persistent financial difficulties and subdued market sentiment.
Read full news article
Nectar Lifescience Ltd witnessed a sharp decline on 9 Mar 2026, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares plunged to a new 52-week low of ₹11.13, marking a maximum daily loss of 4.18%, significantly underperforming its sector and the broader market.
Read full news article
Nectar Lifescience Ltd’s shares touched a fresh 52-week low of Rs.11.21 today, marking a significant decline amid ongoing financial pressures and subdued market performance. The stock has now fallen for two consecutive sessions, registering a cumulative loss of 6.48% over this period, underperforming its sector by 0.5% on the day.
Read full news article
Nectar Lifescience Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 2 Mar 2026, hitting its lower circuit price limit of ₹11.59. The stock faced intense selling pressure, resulting in a maximum daily loss of 5.0%, signalling panic selling and a significant imbalance between supply and demand.
Read full news articlePlease find attached herewith the Minutes of the Ordinary and Special Resolutions passed by way of Postal Ballot by the Members of the Company as set out in the Postal Ballot Notice dated January 23 2026. The Result of the Postal Ballot was declared on March 01 2026 and communicated to the exchanges vide letter no. NLL/CS/2026- WFH dated March 01 2026.
Please find attached herewith Intimation of inter-corporate loan agreement with Avensis Exports Private Limited a Wholly Owned Subsidiary of the Nectar Lifesciences Limited
Please find attached herewith disclosures under Regulation 30 of the Securities and Exchange of Board of India (Listing obligations and Disclosure Requirements) Regulations 2015
No Upcoming Board Meetings
Nectar Lifescience Ltd has declared 5% dividend, ex-date: 11 Sep 20
Nectar Lifescience Ltd has announced 1:10 stock split, ex-date: 12 Nov 08
No Bonus history available
No Rights history available